Pfizer Inc. said surging sales of key drugs boosted first-quarter profit 22%, but its shares skidded on a warning that higher costs would hold second-quarter earnings well below Wall Street forecasts.
In an unexpected development announced late Sunday evening, Jeffrey B. Kindler stepped down as CEO of Pfizer, the world's biggest drugmaker. Kindler's supporters give him credit for reorganizing most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback